Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Long-Term Deferred Tax (2010 - 2025)

Bio-Techne (TECH) posted quarterly Long-Term Deferred Tax of $10.3 million for Q2 2025, up 1812.24% quarter-over-quarter from $539000.0 in Q1 2011.

Analysis

Bio-Techne (TECH) Long-Term Deferred Tax (2010 - 2025) Analysis & Trends

Bio-Techne's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $10.3 million for Q2 2025.

  • In Q2 2025, Long-Term Deferred Tax changed N/A year-over-year to $10.3 million; the TTM figure through Jun 2025 stood at $10.3 million (changed N/A YoY), while the FY2025 annual figure was $10.3 million, changed N/A from the prior year.
  • Long-Term Deferred Tax for Q2 2025 stood at $10.3 million, up from $539000.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $10.3 million in Q2 2025, with the low at $10.3 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4.14 Mn
Mar 31, 2011 539,000.00
Dec 31, 2010 1.06 Mn
Sep 30, 2010 936,000.00
Jun 30, 2010 1.01 Mn